logo
Search…
home
TOP News
Latest
RecommendHK StockUS StockChina StockMacroBond
Commercial
GlobalInvestment&FinancingCompany&ProductsCharacterESG
Economy&politics
Hong KongChinaAmerica
Stocks
HK StockChina StockUS Stock
Markets
HK StockUS Stock
IPO
Hong KongAmericaChina
Research
US StockHK Stock
Opinion
Recommendation
home
TOP News
Latest
RecommendHK StockUS StockChina StockMacroBond
Commercial
GlobalInvestment&FinancingCompany&ProductsCharacterESG
Economy&politics
Hong KongChinaAmerica
Stocks
HK StockChina StockUS Stock
Markets
HK StockUS Stock
IPO
Hong KongAmericaChina
Research
US StockHK Stock
Opinion
Recommendation
Search...
search
home
TOP News
Latest
RecommendHK StockUS StockChina StockMacroBond
Commercial
GlobalInvestment&FinancingCompany&ProductsCharacterESG
Economy&politics
Hong KongChinaAmerica
Stocks
HK StockChina StockUS Stock
Markets
HK StockUS Stock
IPO
Hong KongAmericaChina
Research
US StockHK Stock
Opinion
Recommendation
Home > Stocks > HK Stock

VITASOY INT'L (00345) repurchased 432,000 shares at a cost of HKD 2.7966 million on August 4.

date
16:47 04/08/2026
avatar
GMT Eight
VITASOY INT'L (00345) announced that it spent HKD 2.7966 million to repurchase 432,000 shares on August 4, 2026.
VITASOY INT'L (00345) announced that on August 4, 2026, it spent HKD 2.7966 million to buy back 432,000 shares.
Related Articles
HK Stock
KARRIE INT'L (01050) spent HK$372,200 to repurchase 200,000 shares on August 4.
HK Stock
TECHTRONIC IND (00669) announced its interim results, with a profit attributable to shareholders of $738 million, an increase of 17.52% year-on-year.
China Stock
Jiangsu Hengrui Pharmaceuticals (600276.SH) subsidiary has obtained the drug clinical trial approval notice.
KARRIE INT'L (01050) spent HK$372,200 to repurchase 200,000 shares on August 4.
HK Stock
TECHTRONIC IND (00669) announced its interim results, with a profit attributable to shareholders of $738 million, an increase of 17.52% year-on-year.
HK Stock
Jiangsu Hengrui Pharmaceuticals (600276.SH) subsidiary has obtained the drug clinical trial approval notice.
China Stock
RECOMMEND
Hot A‑Share Stocks Clarify Physical AI, Robotics, Aerospace, and Duty‑Free Themes Amid Frenzied Trading
Hot A‑Share Stocks Clarify Physical AI, Robotics, Aerospace, and Duty‑Free Themes Amid Frenzied Trading
icon
10/06/2026
U.S. AI Trading Frenzy Collapses as Jobs Data Fuels Fed Hike Fears
U.S. AI Trading Frenzy Collapses as Jobs Data Fuels Fed Hike Fears
icon
10/06/2026
Goldman Sachs Warns of AI‑Driven Market Heat, But Bubble Indicators Still Below Historical Extremes
Goldman Sachs Warns of AI‑Driven Market Heat, But Bubble Indicators Still Below Historical Extremes
icon
10/06/2026
logo
Contact US
qr
+852 - 60190728
[email protected]
Customer Support
About Us
Contact Us
Frequently Asked
Privacy Policy
Terms of Use
Commercial Services
Advertising
Business Development
Copyright
Terms of Service
©️2013 - 2026 GMT EIGHT Holdings. All Rights Reserved.